ClinicalTrials | Financial Buzz

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Vertex Pharma and CRISPR Therapeutics Release Data on 22 Patients on Gene-Editing Therapy

Andy Liao06/11/2021

3199

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) reported new data on 22 patients, following up at a minimum of 3 months post gene-editing therapy. CTX001 has...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Annovis Bio Inc. (NASDAQ: ANVS) Releases Alzheimer’s, Parkinson’s Study Results

financial buzz05/21/2021

1893

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Annovis Bio Inc. On the Rise After Releasing Alzheimer’s, Parkinson’s Study Results” Annovis Bio Inc. (NASDAQ: ANVS) surged...

Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: DGTL Holdings Inc. (OTCQB: DGTHF) (TSX-V: DGTL) Healthcare Contract

financial buzz04/20/202104/27/2021

5873

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “DGTL Holdings Inc. Secures New Campaign Contract with NASDAQ Listed Healthcare Client.” DGTL Holdings Inc.(OTCQB: DGTHF)...

AI Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: DGTL Holdings Inc. Secures New Campaign Contract with NASDAQ Listed Healthcare Client

financial buzz04/20/2021

5341

DGTL Holdings Inc.(OTCQB: DGTHF) (TSX-V: DGTL) (FSE: A2QB0L) (“DGTL” or the “Company”) reports that its wholly owned subsidiary, Hashoff LLC, has secured a new service contract with a NASDAQ...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Affimed N.V (NASDAQ: AFMD) Announces Positive Initial Clinical Data

financial buzz04/09/2021

2205

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Affimed N.V Announces Positive Initial Clinical Data” Affimed N.V. (NASDAQ: AFMD) surged over 30% in premarket trading after...

Breaking News Buzz On The Street Cannabis Buzz Healthcare Market News Medical Use Pharmaceutical Products Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: HempFusion Wellness (OTCQX: CBDHF) (TSX: CBD.U) Completes Pilot Study

financial buzz03/29/202104/13/2021

5778

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper” HempFusion Wellness Inc. (OTCQX: CBDHF) (TSX: CBD.U),...

Breaking News Cannabis Buzz Investing News Market News Pharmaceutical Products Recreational Use The Market Buzz

Breaking News: HempFusion Completes Inflammatory Markers Pilot Trial, Releases White Paper

financial buzz03/25/2021

4278

HempFusion Wellness Inc. (OTCQX:CBDHF) (TSX: CBD.U) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce it...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Rebecca Urena03/22/2021

2177

A U.S. trial found that AstraZeneca (OTCMKTS: AZNCF) and the University of Oxford’s coronavirus vaccine was 79% effective in preventing the covid-19 virus. Furthermore the vaccine is 100% effective...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Mydecine Innovations (OTC: MYCOF) (CSE: MYCO) Export of Psilocybin

financial buzz03/01/202103/04/2021

5111

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

financial buzz03/01/202103/01/2021

10130

Mydecine Innovations Group (OTC: MYCOF) (CSE: MYCO) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category committed to the research and development, production,...

Tag: ClinicalTrials